Xoma Corp $4.22

down -0.11


17/4/2014 03:47 PM  |  NASDAQ : XOMA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get XOMA Trend Analysis - it has outperformed the S&P 500 by 4%

Partner Headlines

  1. Benzinga's Top Downgrades

    Benzinga
  2. UPDATE: MLV & Co Downgrades XOMA on Valuation/Sentiment

    Benzinga
  3. Mid-Afternoon Market Update: FuelCell Energy Hangs on to Gains as Canadian ...

    Benzinga
  4. Mid-Day Market Update: Smith & Wesson Surges On Upbeat Results; XOMA Shares ...

    Benzinga
  5. Mid-Morning Market Update: Markets Mostly Flat; Brown-Forman Posts Higher ...

    Benzinga
  6. Morning Lowers for Mar. 5, 2014: XOMA, USU, CSIQ, AUDC, RATE

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. UPDATE: XOMA Offers Update on Gevokizumaba, Says Results Do Not Support ...

    Benzinga
  9. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, XOMA, ...

    Benzinga
  10. Stocks Hitting 52-Week Highs

    Benzinga
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. XOMA Announces Closing of the Offering and Exercise of 1.425M Share Over ...

    Benzinga
  13. XOMA Announces Pricing of 9.5M Shares at $5.25 per Share

    Benzinga
  14. XOMA Prices 9.5M Share Offering at $5.25/Share

    Benzinga
  15. Benzinga's Top #PreMarket Losers

    Benzinga
  16. Benzinga's Top #PreMarket Gainers

    Benzinga
  17. Xoma Shares Rise 6% After-Hours on Encouraging Phase 2 Gevokizumab Results

    Benzinga
  18. XOMA Shares Quiet Following Results of Two Phase 2 Trials Showing Gevokizumab ...

    Benzinga
  19. UPDATE: Piper Jaffray Initiates XOMA at Overweight on 'Xciting Antibody ...

    Benzinga
  20. Benzinga's Top Initiations

    Benzinga
  21. Benzinga's Top Pre-Market Losers

    Benzinga
  22. UPDATE: Wedbush Raises PT to $5 on Xoma on Gevokizumab Initial Efficacy

    Benzinga
  23. XOMA Says Sevier Initiated Proof-of-Concept Gevokizumab Study for Acute ...

    Benzinga
  24. XOMA Corp (XOMA) CFO & VP Finance Fred Kurland sells 9,111 Shares

    GuruFocus
  25. XOMA Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients ...

    Benzinga
  26. UPDATE: XOMA Receives Orphan Drug Designation From FDA for Gevokizumab

    Benzinga
  27. XOMA Ltd. Reports Operating Results (10-Q)

    GuruFocus
  28. CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility; Terms Not ...

    Benzinga
  29. Oncobiologics Announces Agreement To Utilize XOMA's Fully Human Antibody ...

    Benzinga
  30. Health Care Sector Wrap

    FoxBusiness
  31. Benzinga's Top Initiations

    Benzinga
  32. Earnings Scheduled For March 6

    Benzinga
  33. End-of-Day Market Summary for January 17, 2012

    Benzinga
  34. Xoma Shares Down After Job Cuts and One Time Charges Announced

    Benzinga
  35. Benzinga's Microcap Movers for Thursday January 5, 2012

    Benzinga
  36. XOMA Streamlines Operations to Invest in Value-Creating Activities; Cuts ...

    Benzinga
  37. XOMA Corporation New CEO Says Company Expects to Initiate Global Gevokizumab ...

    Benzinga
  38. XOMA Appoints John Varian as Chief Executive Officer

    Benzinga
  39. XOMA Will Move Its Corporate Domicile to Delaware

    Benzinga
  40. XOMA Initiates Gevokizumab Phase 2 Study for Moderate to Severe Acne Vulgaris

    Benzinga
Trading Center